Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?

Area of Science:

• Cardiology
• Cardiac Electrophysiology

Background:

• Implantable cardioverter-defibrillators (ICDs) are a standard therapy for preventing sudden cardiac death (SCD) in patients with chronic coronary artery disease (CAD).
• Previous research confirms ICD superiority over antiarrhythmic drugs in patients with a history of ventricular tachycardia (VT) or ventricular fibrillation (VF).

Purpose of the Study:

• To evaluate the role of ICD therapy in primary prevention of SCD in high-risk CAD patients without a history of VT or VF.
• To assess the impact of ICDs on mortality in selected CAD patients with severe left ventricular (LV) dysfunction and a ventricular scar.

Main Methods:

• Review of a decade of studies on ICD therapy versus antiarrhythmic drugs.
• Analysis of recent studies investigating ICDs for primary prophylaxis in high-risk CAD patients.

Main Results:

• ICDs significantly prolong survival compared to antiarrhythmic drugs in patients with prior sustained VT or VF.
• In selected high-risk CAD patients with ventricular scarring, ICDs demonstrated significant relative and absolute reductions in mortality, even without a history of VT/VF.

Conclusions:

• ICD therapy is a crucial intervention for preventing SCD in chronic CAD patients.
• Clinicians should consider ICDs for primary prevention in CAD patients with severe LV dysfunction and a ventricular scar, even without a history of VT/VF.